MoonLake Immunotherapeutics Class A Ordinary Shares
XNAS:MLTX
15.1
$15.12 - 200.00
$14.91 - 30.00
$14.84
$15.34
$15.06
$15
62.75
5.95
1255558
2060367.5
62773063.52
Chart
TendieTensor AI Analysis
Company
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.
Fundamentals
100
-4.480000
3.306440
100
BBG00XQZQTS9
BBG00XQZQVP7
63.50M
70.85M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own MLTX. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.